Lesions of the nigro-neostriatal dopamine neurons or the bulbo-spinal norepinephrine and 5-hydroxytryptamine neurons in rats: action of drugs

Review

N E Andén. Pharmacol Ther B. 1975.

. 1975;1(3):371-80.

doi: 10.1016/0306-039x(75)90043-4.

No abstract available

Similar articles

Stimulation by dopamine of adenosine cyclic 3',5'-monophosphate formation in rat caudate nucleus: effect of lesions of the nigro-neostriatal pathway.
Krueger BK, Forn J, Walters JR, Roth RH, Greengard P. Krueger BK, et al. Mol Pharmacol. 1976 Jul;12(4):639-48. Mol Pharmacol. 1976. PMID: 183096 No abstract available.
Antiparkinsonian drugs and dopaminergic neostriatal mechanisms: studies in rats with unilateral 6-hydroxydopamine (=6-OH-DA)-induced degeneration of the nigro-neostriatal DA pathway and quantitative recording of rotational behaviour.
Fuxe K, Ungerstedt U. Fuxe K, et al. Pharmacol Ther B. 1976;2(1):41-7. doi: 10.1016/0306-039x(76)90017-9. Pharmacol Ther B. 1976. PMID: 817332 Review. No abstract available.
[Stereotyped behavior and the nigro-strio-nigral system].
Arushanian EB. Arushanian EB. Zh Vyssh Nerv Deiat Im I P Pavlova. 1985 Sep-Oct;35(5):819-32. Zh Vyssh Nerv Deiat Im I P Pavlova. 1985. PMID: 2866641 Review. Russian. No abstract available.
Electrophysiology of the nigro-putamen dopamine pathway.
York DH. York DH. Pharmacol Ther B. 1976;2(1):1-7. doi: 10.1016/0306-039x(76)90012-x. Pharmacol Ther B. 1976. PMID: 772715 Review. No abstract available.
Central catecholamine neuron systems: anatomy and physiology of the dopamine systems.
Moore RY, Bloom FE. Moore RY, et al. Annu Rev Neurosci. 1978;1:129-69. doi: 10.1146/annurev.ne.01.030178.001021. Annu Rev Neurosci. 1978. PMID: 756202 No abstract available.

Normalization by antipsychotic drugs of biochemically induced abnormal behavior in rats.
Ahlenius S, Engel J. Ahlenius S, et al. Psychopharmacology (Berl). 1976 Aug 26;49(1):63-8. doi: 10.1007/BF00427472. Psychopharmacology (Berl). 1976. PMID: 822449
Synthesis rate of dopamine: difference between corpus striatum and limbic system as a possible explanation of variations in reactions to drugs.
Andén NE, Grabowska-Andén M, Lindgren S, Thornström U. Andén NE, et al. Naunyn Schmiedebergs Arch Pharmacol. 1983 Jul;323(3):193-8. doi: 10.1007/BF00497662. Naunyn Schmiedebergs Arch Pharmacol. 1983. PMID: 6621714